Cargando…

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma

Neuroblastoma is a pediatric cancer of the developing sympathetic nervous system. High-risk neuroblastoma patients typically undergo an initial remission in response to treatment, followed by recurrence of aggressive tumors that have become refractory to further treatment. The need for biomarkers th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Utnes, Peter, Løkke, Cecilie, Flægstad, Trond, Einvik, Christer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413431/ https://www.ncbi.nlm.nih.gov/pubmed/30886518 http://dx.doi.org/10.1177/1176935119832910

Ejemplares similares

Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells
por: Bhavsar, Swapnil Parashram, et al.
Publicado: (2023)

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
por: Henriksen, Jørn R, et al.
Publicado: (2011)

MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN
por: Roth, Sarah Andrea, et al.
Publicado: (2018)

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
por: Hald, Øyvind H., et al.
Publicado: (2018)

Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines
por: Henriksen, Jørn R., et al.
Publicado: (2007)

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
por: Buechner, J, et al.
Publicado: (2011)

Integrative discovery of treatments for high-risk neuroblastoma
por: Almstedt, Elin, et al.
Publicado: (2020)

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
por: Tang, Xao X., et al.
Publicado: (2021)

Clinical relevance of hyponatraemia in olfactory neuroblastoma
por: Devaraja, K., et al.
Publicado: (2023)

Patterns of recurrence after radiation therapy for high-risk neuroblastoma
por: Jo, Ji Hwan, et al.
Publicado: (2019)

Physiologically-Relevant Cellular Models for Biomarkers and Drug Discovery
por: Jeffrey, Araceli Espinosa
Publicado: (2018)

Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
por: Sen, Arko, et al.
Publicado: (2022)

Prevalence and Risk Factors for Post-Traumatic Stress in Hospitalized and Non-Hospitalized COVID-19 Patients
por: Einvik, Gunnar, et al.
Publicado: (2021)

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
por: Mañas, Adriana, et al.
Publicado: (2022)

Bottom-Up Approach to the Discovery of Clinically Relevant Biomarker Genes: The Case of Colorectal Cancer
por: Kamel, Faddy, et al.
Publicado: (2022)

A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature)
por: Yang, Xinan (Holly), et al.
Publicado: (2017)

Treatment of high-risk neuroblastoma
por: Sung, Ki Woong
Publicado: (2012)

Treatment of High-Risk Neuroblastoma
por: Krystal, Julie, et al.
Publicado: (2023)

Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma
por: Feng, Lijuan, et al.
Publicado: (2022)

Discovery of clinically relevant fusions in pediatric cancer
por: LaHaye, Stephanie, et al.
Publicado: (2021)

Single versus multiple-family intervention in childhood overweight—Finnmark Activity School: a randomised trial
por: Kokkvoll, Ane, et al.
Publicado: (2014)

Health in overweight children: 2-year follow-up of Finnmark Activity School—a randomised trial
por: Kokkvoll, Ane, et al.
Publicado: (2015)

AI in drug discovery and its clinical relevance
por: Qureshi, Rizwan, et al.
Publicado: (2023)

CD47 antibody inhibits tumor recurrence in a clinical relevant glioblastoma animal model
por: Zhu, Huaiyang, et al.
Publicado: (2015)

Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis
por: De Paoli, Marine, et al.
Publicado: (2016)

The genetic landscape of high-risk neuroblastoma
por: Pugh, Trevor J., et al.
Publicado: (2013)

High-Risk Neuroblastoma Treatment Review
por: Smith, Valeria, et al.
Publicado: (2018)

Computational Identification of Gene Networks as a Biomarker of Neuroblastoma Risk
por: Sun, Lidan, et al.
Publicado: (2020)

Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma
por: Su, Yan, et al.
Publicado: (2020)

Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging
por: Wu, Zhiyang, et al.
Publicado: (2021)

A single center clinical analysis of children with high-risk neuroblastoma
por: Tian, Xiangdong, et al.
Publicado: (2017)

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
por: Makvandi, Mehran, et al.
Publicado: (2022)

Protein biomarker discovery is still relevant and has entered a new phase
por: van der Burgt, Yuri E.M.
Publicado: (2019)

Discovery of stat3 signalling and its clinical relevance
por: Horn, Friedemann
Publicado: (2011)

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors
por: Suenaga, Yusuke, et al.
Publicado: (2021)

Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman, Wayne L
Publicado: (2021)

High-Risk Neuroblastoma: A Surgical Perspective
por: Jacobson, Jillian C., et al.
Publicado: (2023)

Protein kinase Cepsilon is important for migration of neuroblastoma cells
por: Stensman, Helena, et al.
Publicado: (2008)

Maintenance DFMO Increases Survival in High Risk Neuroblastoma
por: Sholler, Giselle L. Saulnier, et al.
Publicado: (2018)

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
por: Combaret, V., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_nm7fde1v48jcs1qlbpjtgjp9nv